8-K: APX Acquisition Corp. I Secures $700,000 Loan at 20% Interest for Business Combination

APX Acquisition Corp. I has entered into a promissory note agreement for $700,000 with Bioceres LLC, carrying a 20% annual interest rate, to fund working capital and business combination expenses.

Summary

• APX Acquisition Corp. I has issued a promissory note to Bioceres LLC for up to $700,000.
• The note carries a 20% annual interest rate.
• The principal and accrued interest are due upon the completion of APX's initial business combination.
• The funds will be used for working capital and payments related to the business combination.
• The note is unsecured and subject to customary events of default.
• Drawdowns can be requested in amounts of at least $1,000, up to the $700,000 limit.
• The note is governed by the laws of New York.

Sentiment

Score: 4

Explanation: The high interest rate on the loan is a negative factor, suggesting a higher risk profile for the company. While the funding is necessary, the terms are not favorable.

Positives

• The promissory note provides APX Acquisition Corp. I with necessary funding for its working capital and business combination.
• The note allows for flexible drawdowns as needed, up to the $700,000 limit.

Negatives

• The 20% annual interest rate on the promissory note is very high.
• The full principal and accrued interest are due upon the completion of the business combination, creating a significant repayment obligation.
• The note is unsecured, which could pose a risk to Bioceres LLC if APX defaults.

Risks

• The high interest rate of 20% could significantly increase the cost of the loan for APX.
• Failure to complete the business combination would trigger an event of default, potentially leading to immediate repayment obligations.
• The unsecured nature of the note means Bioceres LLC has limited recourse if APX defaults.
• The company's ability to repay the note is dependent on the successful completion of the business combination.

Future Outlook

The company's ability to repay the note is contingent on the successful completion of its business combination. The note is intended to provide the necessary funding to complete the business combination.

Management Comments

• Kyle Bransfield, Chief Executive Officer of APX Acquisition Corp. I, signed the report on behalf of the company.
• Federico Trucco, President of Bioceres LLC, accepted and agreed to the terms of the promissory note.

Industry Context

This type of financing is common for SPACs (Special Purpose Acquisition Companies) like APX Acquisition Corp. I, as they often need bridge financing to complete their business combinations. The high interest rate reflects the risk associated with these types of transactions.

Comparison to Industry Standards

• The 20% interest rate is significantly higher than typical corporate loan rates, which usually range from 5% to 10% for established companies.
• SPACs often use promissory notes or similar instruments for short-term financing, but the interest rates can vary widely depending on the risk profile of the SPAC and the lender.
• Comparable companies in the SPAC space have secured similar bridge financing, but the terms and interest rates are often negotiated on a case-by-case basis.
• The terms of the note, including the repayment trigger upon business combination, are standard for SPAC financing.

Related Party Transactions

• The promissory note was issued to Bioceres LLC, an indirect shareholder of OmnigenicsAI Corp, the counterparty to the Companys previously announced business combination, indicating a related party transaction.

Stakeholder Impact

• Shareholders of APX Acquisition Corp. I may be concerned about the high interest rate on the loan and the potential impact on the company's financial position.
• The successful completion of the business combination is crucial for the repayment of the note and the future of the company.
• Bioceres LLC, as the lender, is exposed to the risk of default by APX.

Next Steps

• APX Acquisition Corp. I will continue to work towards completing its business combination.
• The company will draw down funds from the promissory note as needed for working capital and business combination expenses.

Key Dates

Keywords

promissory note, business combination, financing, acquisition, interest rate, working capital, Bioceres LLC, APX Acquisition Corp. I